July 25 (Reuters) - Monsanto will pay $160 million to settle a lawsuit by the city of Seattle that accused the unit of Germany's Bayer (BAYGn.DE), opens new tab of polluting the city's drainage system and the local Lower Duwamish River with toxic chemicals known as PCBs.
CANBERRA, July 25 (Reuters) - An Australian judge on Thursday dismissed a class action lawsuit claiming Bayer's (BAYGn.DE), opens new tab Roundup weedkiller can cause a type of blood cancer, a boost for the company which is grappling with a slew of similar cases in the United States.
July 22 (Reuters) - A former unit of German life-sciences giant Bayer (BAYGn.DE), opens new tab is squaring off in California federal court this week with a petcare startup that claims the company tried to block competition for animal tick and flea treatments.
Bayer eyes wider Nubeqa use on new prostate cancer trial data
ORIC-944, a potential best-in-class PRC2 inhibitor, is being evaluated in combination with darolutamide and in combination with apalutamide in patients with mCRPC ORIC entered into clinical trial...
Bayer and Asklepios BioPharmaceutical (AskBio) have announced US Food and Drug Administration (FDA) fast track designation for AB-1005, a gene therapy to treat moderate Parkinson’s disease (PD).
Bayer’s massive reorganization championed by CEO Bill Anderson is bringing major changes to the German company’s pharma commercial team, shaking up its structure, personnel and operations.
One A Day® Launches Science-Backed Cellular Aging Support Supplement
Roche's launch of eye implant Susvimo was stopped short in 2022 after manufacturing concerns led to a market withdrawal. Now, with the FDA’s blessing to reintroduce the therapy, the rollout can resume.
Bayer and Rad AI Announce Collaboration agreement